Closed · RFA-CK-16-005 · CFDA 93.084 · Discretionary

Evaluating the Impact of Non-pharmaceutical Measures on the Incidence of Influenza-like Illness (ILI) among K-12 Students in the United States

Federal grant opportunity posted by Centers for Disease Control and Prevention - ERA, cataloged on Grants.gov.

$400K-$500K
Award range
Closed
Status
January 15, 2016
Close date
2
Expected awards

The verdict

Evaluating the Impact of Non-pharmaceutical Measures on the Incidence of Influenza-like Illness (ILI) among K-12 Students in the United States is a closed discretionary listing from Centers for Disease Control and Prevention - ERA that offered $400,000 -- $500,000 across 2 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 639 other opportunities from Centers for Disease Control and Prevention - ERA.

$400K-$500K
award range
Closed
application status
2
expected awards
93.084
CFDA program

Archived opportunity record

Evaluating the Impact of Non-pharmaceutical M… is closed (last close January 15, 2016). Check the agency catalog for replacement NOFOs. Centers for Disease Control and Prevention - ERA still indexes 639 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed January 15, 2016

Posted Nov 13 Closes Jan 15

Est. Total Funding

$4,000,000

Expected Awards

2

Instrument

Cooperative Agreement

Description

The project aims to evaluate the impact of non-pharmaceutical measures (NPIs) on incidence of influenza-like infections (ILI) among K-12 students in the United States via multi-year community randomized trials. The NPIs of interest will include at least one social distancing measure of interest, and an improved personal hygiene (hand washing and/or alcohol-based hand sanitizer use) and environmental hygiene practice (cleaning of frequently touched surfaces) within schools. The social distancing measures of interest include, but are not limited to, (1) reducing class size to allow for increases in space between students to at least 3 ft, and (2) reducing duration of the school day (e.g. by offering a certain proportion of daily school instruction via remote learning systems). Additionally, use of disposable medical face masks can be included as a source control measure for students exhibiting respiratory symptoms with or without fever while at school. The outcomes of interest include (1) incidence of ILI-associated student absenteeism and (2) incidence of laboratory-confirmed respiratory infections as detected by multiplex PCR assay.

Wide-open applicant board · 15 Grants.gov doors

Evaluating the Impact of Non-pharmaceutical M… prints 15 distinct Grants.gov eligibility doors (State governments; County governments; City or township governments; Special district governments; +11 more). Filter fit before reading award size as demand — most applicant classes appear on the row. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Health (HL). Only 28 other Centers for Disease Control and Prevention - ERA listings share this exact eligibility-code string (4% of 640).

Code 00
State governments
Code 01
County governments
Code 02
City or township governments
Code 04
Special district governments
Code 05
Independent school districts
Code 06
Public / state-controlled institutions of higher education
Code 07
Federally recognized tribal governments
Code 08
Public / Indian housing authorities
Code 11
Native American tribal organizations (other than Federally recognized tribal governments)
Code 12
Nonprofits with 501(c)(3) status (other than IHEs)
Code 13
Nonprofits without 501(c)(3) status (other than IHEs)
Code 20
Private institutions of higher education
Code 22
For-profit organizations other than small businesses
Code 23
Small businesses
Code 25
Others (see official listing text)

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Deborah Loveys hft6@cdc.gov

What to do next

Evaluating the Impact of Non-pharmaceutical M… is closed; use the parent program and agency catalog for the next funding cycle.

  • Browse open federal opportunities in the same category when this listing is closed. Open opportunities
  • Look up CFDA 93.084 across all indexed listings before you commit to this opportunity alone. Eligibility finder
  • Compare award ranges across federal categories before you pick a single CFDA. All categories

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants